Search research articles
Contact Us
Filters
Showing results (21-30 of 117) with videos related to
Page
of 12
Sort By:
Blood
|
July 20, 2023
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells
Philipp Karschnia, Kevin C Miller, Andrew J Yee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 1, 2023
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
Hazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
Hematological Oncology
|
October 5, 2023
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma
Hazim S Ababneh, Andrea K Ng, Jeremy S Abramson, et al.
Haematologica
|
June 15, 2023
Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2020
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
Eric A Meyerowitz, Pritha Sen, Sara R Schoenfeld, et al.
Transplantation and Cellular Therapy
|
February 15, 2025
Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells
Frederick L Locke, Zahra Mahmoudjafari, Partow Kebriaei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 25, 2020
Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel
Meghan D Lee, Ian A Strohbehn, Harish S Seethapathy, et al.
Blood Advances
|
April 9, 2025
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma
Joshua N Gustine, Andrew R Branagan, Diana D Cirstea, et al.
Transplantation and Cellular Therapy
|
March 13, 2026
Characterization of Hypogammaglobulinemia, Infection Incidence, and Mortality in Patients Receiving B-cell Maturation Antigen Chimeric Antigen Receptor (CAR) T-cell Therapy
Katherine J Liu, Lingxiao Zhang, Baijun Zhou, et al.
Circulation
|
November 25, 2024
Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
Osnat Itzhaki Ben Zadok, Panagiotis Simitsis, Caron Jacobson, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 117) with videos related to
Sort By:
Page
of 12
Blood
|
July 20, 2023
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells
Philipp Karschnia, Kevin C Miller, Andrew J Yee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 1, 2023
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
Hazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
Hematological Oncology
|
October 5, 2023
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma
Hazim S Ababneh, Andrea K Ng, Jeremy S Abramson, et al.
Haematologica
|
June 15, 2023
Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2020
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
Eric A Meyerowitz, Pritha Sen, Sara R Schoenfeld, et al.
Transplantation and Cellular Therapy
|
February 15, 2025
Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells
Frederick L Locke, Zahra Mahmoudjafari, Partow Kebriaei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 25, 2020
Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel
Meghan D Lee, Ian A Strohbehn, Harish S Seethapathy, et al.
Blood Advances
|
April 9, 2025
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma
Joshua N Gustine, Andrew R Branagan, Diana D Cirstea, et al.
Transplantation and Cellular Therapy
|
March 13, 2026
Characterization of Hypogammaglobulinemia, Infection Incidence, and Mortality in Patients Receiving B-cell Maturation Antigen Chimeric Antigen Receptor (CAR) T-cell Therapy
Katherine J Liu, Lingxiao Zhang, Baijun Zhou, et al.
Circulation
|
November 25, 2024
Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
Osnat Itzhaki Ben Zadok, Panagiotis Simitsis, Caron Jacobson, et al.
Page
of 12